Trial intelligence / Profile preview

Dexmedetomidine versus midazolam premedication for elective laparoscopic cholecystectomy

ACTRN12622001388707Phase 4Not yet recruiting

Sponsor
Department of Anestesiology, Intesive Care Medicine and Pain Managment of the Clinical Hospital Center of "Sister of Mercy" Zagreb
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in anxiety disorder comparing Dexmedetomidine premedication with Midazolam premedication (2 arms). Primary endpoints: Plasma ACTH level, Noninvasive blood pressure and 1 more. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

dexmedetomidinemidazolam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on ACTRN12622001388707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12622001388707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call